Find out what’s needed to give people faster and fairer access to the latest treatments, so they can live longer, healthier lives. Visit: www.abpi.org.uk/reputation/b...

On the resignation of Lord Vallance, Richard Torbett said: “Lord Vallance has been a tremendous Science Minister and a genuine champion for the UK's life sciences sector. He has been instrumental in beginning to turn around international sentiment towards the UK as a life sciences destination."

This landmark agreement between the UK and Switzerland, two nations with a long history of collaboration in life sciences, is built on a shared understanding of what is needed to support innovation and bring new medicines to patients. www.gov.uk/government/n...

UK Switzerland FTA Top Benefits

11 top benefits of the largest services trade deal concluded by the UK

gov.uk

Today we have published the latest Disclosure UK data. Disclosure UK records payments & benefits in kind made by pharmaceutical companies to healthcare professionals, healthcare organisations and NHS organisations. Read our latest blog post here: www.abpi.org.uk/media/blogs/...

Disclosure UK 2025: the 11th year of Disclosure UK data, with industry transparency continuing to grow

Dr Amit Aggarwal, ABPI Executive Director of Medical Affairs and Strategic Partnerships, and Alex Fell, PMCPA Chief Executive, discuss the latest data published on Disclosure UK, the industry database...

abpi.org.uk

Today we've gone #Red4Research! 🧬 🔬 🩺 Through industry clinical research, scientific breakthroughs can become life-changing medicines for patients. Thank you to all the scientists, clinicians, & patients who make health and care research happen. 🔴 @nihr.bsky.social @hralatest.bsky.social

Following a consultation, the Department of Health and Social Care will implement its proposals to reduce the statutory scheme's headline payment percentage for 2026 and beyond to 16.5%, maintaining broad commercial equivalence with the Voluntary Scheme. www.gov.uk/government/c...

Proposed 2026 changes to the statutory scheme for branded medicines pricing

Proposed changes to the headline payment percentage and consultation procedure of the statutory scheme to control the cost of branded health service medicines.

gov.uk

Pleased to be supporting the Newcomer of the Year award at this years @absw.bsky.social awards! Good luck to all finalists!

ABSW@absw.bsky.social · 2mo ago

📣 #ABSWawards Finalists announced! 🔗 zurl.co/ghOYq Of note this year were the range of pieces focused on the cuts to scientific research funding in the USA. UK and Irish journalists investigated the impact on individuals, institutions and communities both in the USA and internationally.

On International Clinical Trials Day, we're highlighting the importance of clinical trials, without which we would have no new medicines or vaccines. Dr Janet Valentine explains below. #ICTD @nihr.bsky.social @hralatest.bsky.social @mhragovuk.bsky.social www.youtube.com/watch?v=PaqV...

The clinical trial process

YouTube video by Association of the British Pharmaceutical Industry

youtube.com

Delighted to welcome a new @plaidcymru.bsky.social government under @rhunapiorwerth.bsky.social's leadership. We will continue our work to support equitable access to innovation, drive health & economic ambitions to deliver better health outcomes for people in Wales. www.abpi.org.uk/publications...

Plaid Cymru@plaidcymru.bsky.social · 3mo ago

Prif Weinidog Cymru - Rhun ap Iorwerth. Rhun ap Iorwerth - your new First Minister of Wales. 🏴󠁧󠁢󠁷󠁬󠁳󠁿

📋 New blog from ABPI's Sophie Caseby unpacking the latest EFPIA W.A.I.T. Indicator report. England ranks 7th in Europe for access to newly approved medicines overall — but 14th for cancer treatments. What's driving the gap, and what needs to change? 👇 www.abpi.org.uk/media/blogs/...

Are NHS patients keeping up with European neighbours on access to new medicines?

NHS patients in England rank 7th in Europe for access to newly approved medicines, according to the latest EFPIA W.A.I.T. Indicator report — but significant gaps remain, particularly for cancer and ra...

abpi.org.uk

Medicines supply issues are relatively rare, but when they happen, they can have a serious impact on patients. Our new report sets out how to improve the supply chain to anticipate risks and respond quickly when disruption occurs. Read more: www.abpi.org.uk/publications...

Decentralised or hybrid clinical trials can bring research closer to home - boosting access & inclusion. A new @acmedsci.bsky.social report, supported by us + @nihr.bsky.social shows how to encourage more of these trials: choice, trust & clearer guidance. acmedsci.ac.uk/file-downloa...

We are celebrating World Immunization Week🎉 Vaccines have safely protected people, families, and communities for generations and as part of our free learning resources for schools you can find out more about the importance of vaccinations with Ellie. www.abpischools.org.uk/topics/ellie...

The panel discussed how co-creation between industry, academia, government and the NHS is essential to remove barriers and expand access to research. #ABPIconf26

Next up is our clinical trials panel! Improvements in regulatory performance, alongside the UK’s unique health data assets, are strengthening the environment for commercial and non commercial clinical trials. For industry, the priorities are clear: predictability, accuracy and speed. #ABPIconf26

The ABPI Exam offers qualifications for industry personnel to have the understanding they need to promote medicines ethically. Each year, we recognise the candidate who has achieved the highest grade. Congratulations to Pedro Figueiredo Aparicio from Johnson & Johnson Innovative Medicine UK! 🎉👏🏆

Panellists pointed to the value of bringing together industry, government, academia and the health system to unlock the UK’s full potential. #ABPIconf26

A strong start to today’s growth panel on where the UK can win globally. The discussion pointed to a clear opportunity for the UK at the intersection of life sciences and AI, with healthcare seen as one of the most promising settings for innovation to flourish. #ABPIconf26

Opening, our Chief Executive said the UK is starting to choose growth, innovation and faster patient access to medicines. We've long known of problems in the UK - 102 medicines launched in the US have not launched in European markets, vs 15 the other way round.

Our annual conference is underway! We’re looking forward to a full agenda discussing how best to position the UK as a leading place to research, develop and use innovative medicines. #ABPIconf26

Vaccination is one of the most effective ways to protect people’s health, preventing illness and reducing pressure on the NHS. Find out more about the value of vaccination: www.abpi.org.uk/value-and-ac... #Vaccination #EIW2026 #WIW2026

Vaccine Engagement Day 2026 has arrived! 🎉 Let’s come together to #CelebrateVaccines by sharing information and enhancing public awareness about vaccines!🌟 Discover how you can participate: vist.ly/4v2vi

The use of NHS data has the potential to transform commercial clinical trials in the UK by making recruitment faster, more efficient, and participation more inclusive. Read our latest report: “Globally competitive UK-wide data-enabled clinical trials: the time is now www.abpi.org.uk/publications...

NHS–industry partnerships are essential for high-quality healthcare. But they can mean conflicts of interest. Read our blog that explains the safeguards on this - including our strict Code of Practice & independent regulation. 📖 Read more: www.abpi.org.uk/media/blogs/...

Innovation with integrity: Why NHS-industry partnerships matter, and how conflicts of interest are managed

Dr Amit Aggarwal discusses the importance of NHS-industry relationships, and the safeguards in place to ensure they always put patients and the NHS first.

abpi.org.uk

Strengthening Northern Ireland’s health and economy through life sciences leadership. 🧬🔬💊💉 Read our colleague Marion Laverty's piece on the ABPI's work in Northern Ireland for @hiranihealth.bsky.social hira-ni.com/improving-he...

Improving Health, Supporting Economic Growth | (HIRANI) Health Innovation Research Alliance Northern Ireland

By Marion Laverty, Head of Public Affairs, Northern Ireland, Association of the British Pharmaceutical Industry (ABPI)

hira-ni.com

🚨New video: Understanding Disclosure UK Learn how the pharmaceutical industry’s transparency database works, and how it forms part of wider frameworks for managing conflicts of interest. Watch below ⬇️ www.youtube.com/watch?v=pT5e...

What is Disclosure UK

YouTube video by Association of the British Pharmaceutical Industry

youtube.com

Partnerships between the NHS and the pharmaceutical industry play an important role in improving patient outcomes. Dr Amit Aggarwal sets out why these relationships matter and the safeguards to ensure transparency and manage conflicts of interest. www.abpi.org.uk/media/blogs/...

Innovation with integrity: Why NHS-industry partnerships matter, and how conflicts of interest are managed

Dr Amit Aggarwal discusses the importance of NHS-industry relationships, and the safeguards in place to ensure they always put patients and the NHS first.

abpi.org.uk

NEW: Our Medical Director Dr Amit Aggarwal's comment on NHS-industry partnerships and the safeguards in place to manage conflicts of interest. Companies may also benefit from partnerships, but the priority has to be to put the NHS & patients first. www.abpi.org.uk/media/blogs/...

Innovation with integrity: Why NHS-industry partnerships matter, and how conflicts of interest are managed

Dr Amit Aggarwal discusses the importance of NHS-industry relationships, and the safeguards in place to ensure they always put patients and the NHS first.

abpi.org.uk

Our colleague Brian Duggan spoke at the APPG for Black Health event on increasing diversity in clinical trials @paulettehamiltonmp.bsky.social Lack of diversity in clinical trials is a huge issue that has real consequences for health. Read his reflections: abpi.org.uk/media/blogs/...

This @careersweek.bsky.social we're showcasing the diverse range of roles within the pharmaceutical industry. If you’re exploring your next step or curious about what a career in the industry can look like visit our job cases studies: www.abpi.org.uk/careers/job-... www.youtube.com/watch?v=uaoE...

Inshiya and Nina - Medical Affairs Graduates

YouTube video by Association of the British Pharmaceutical Industry

youtube.com